Ponatinib-d8
- $220 - $531
- Product name: Ponatinib-d8
- CAS: 1562993-37-6
- MF: C29H27F3N6O
- MW: 532.57
- EINECS:
- MDL Number:MFCD22380805
- Synonyms:Ponatinib-d8;[2H8]-Ponatinib;AP24534 D8;Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl-2,2,3,3,5,5,6,6-d8)methyl]-3-(trifluoromethyl)phenyl]-
3 prices
Selected condition:
Brand
- Cayman Chemical
- TRC
- Usbiological
Package
- 1mg
- ManufacturerCayman Chemical
- Product number28905
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$354
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberP688252
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$220
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number462817
- Product descriptionPonatinib-d8
- Packaging1mg
- Price$531
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 28905 | Ponatinib-d8 | 1mg | $354 | 2024-03-01 | Buy |
TRC | P688252 | Ponatinib-d8 | 1mg | $220 | 2021-12-16 | Buy |
Usbiological | 462817 | Ponatinib-d8 | 1mg | $531 | 2021-12-16 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMSO: soluble; Methanol: soluble
form :A solid
color :White to light yellow
solubility :DMSO: soluble; Methanol: soluble
form :A solid
color :White to light yellow
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Ponatinib-d8 is an isotope labelled compound of Ponatinib (P688250). Ponatinib is a tyrosine kinase inhibitors (TKI) and used to treat chronic myeloid leukemia (CML) (1,2,3). Ponatinib is also used in combination with other drugs, such as forskolin, to combat TKI resistance in patient with CML (3), targeted drug in small-cell lung cancer. It is a COVID19-related research product.Suppliers and manufacturers
TargetMol Chemicals Inc.
Amadis Chemical Company Limited
Artis Biotech Co. Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Chengdu Novel Biomedical Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd
Shenzhen Polymeri Biochemical Technology Co., Ltd.
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Manhag Testing Technology Co., Ltd